The effect of triple CFTR modulator therapy and azithromycin on ion channels and inflammation in cystic fibrosis
Background Inflammation in cystic fibrosis (CF) airways is difficult to treat with well-established regimens often including azithromycin (AZ) as an immunomodulatory drug. As AZ has been reported to require CF transmembrane conductance regulator (CFTR) to be able to reduce interleukin (IL)-8 and giv...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2024-12-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/10/6/00502-2024.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|